Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | JAB-2485 |
Synonyms | |
Therapy Description |
JAB-2485 inhibits Aurora Kinase A (AURKA), potentially resulting in decreased cell division and increased apoptosis of AURKA-expressing tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
JAB-2485 | JAB2485|JAB 2485 | Aurka Inhibitors 27 | JAB-2485 inhibits Aurora Kinase A (AURKA), potentially resulting in decreased cell division and increased apoptosis of AURKA-expressing tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05490472 | Phase Ib/II | JAB-2485 | JAB-2485 Activity in Adult Patients With Advanced Solid Tumors | Recruiting | USA | 1 |